Pfizer (PFE) Tops Q2 EPS by 1c, Updates FY EPS Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.65 -0.47%
Revenue Growth %: -4.4%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -4.4%
Financial Fact:
Net income before allocation to noncontrolling interests: 1.32B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.01 better than the analyst estimate of $0.66. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.08 billion.
GUIDANCE:
Pfizer sees FY2017 EPS of $2.54-$2.60, versus the consensus of $2.55. Pfizer sees FY2017 revenue of $52-54 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
